Drawing for SIMPLEXTAS

USPTO serial 97474166

SIMPLEXTAS

Reviewed by CopyMark Law Group

Reg. 7131077Status 700Registered
Filing date
Status date
Registration date
Aug 8, 2023
Examiner
TORPEY, KATHERINE ANN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SIMPLEXTAS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jae Youn Kim

JAE YOUN KIM NOVICK, KIM & LEE, PLLC3251 OLD LEE HIGHWAYSUITE 500FAIRFAX, VA 22030

Goods and services

ClassDescriptionStatusFirst use
010Lancets; immune affinity chromatography apparatus for medical use; capillary tubes for samples for medical use; veterinary apparatus and instruments, namely, surgical apparatus and instruments for veterinary use; veterinary apparatus and instruments, namely, x-ray apparatus for veterinary use; medical apparatus and instruments other than for dental purposes, namely, medical apparatus for monitoring vital signs of patients; medical apparatus and instruments other than for dental purposes, namely, medical apparatus and instruments for treating cardiovascular disease; apparatus for use in medical analysis, namely, medical apparatus for monitoring vital signs of patients; telemetry devices for medical applications; thermometers for medical purposes; diagnostic apparatus for medical purposes, namely, medical diagnostic apparatus for detecting cancer; apparatus for clinical diagnosis, namely, medical diagnostic apparatus for detecting cancer; hematimeters; devices for measuring blood sugar; arterial blood pressure measuring apparatus; blood testing apparatus; apparatus for blood analysis; capillary tubes for blood for medical use; apparatus for taking blood; probes for medical purposes; automatic vaccination apparatusACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 8, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 8, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 23, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 23, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 3, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 20, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 20, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Apr 20, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Apr 20, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Apr 20, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Apr 7, 2023DOCKASSIGNED TO EXAMINER—
Jul 13, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 28, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance